Supporting and optimizing the market approval process
The US FDA underpins the rising need for advanced computational modeling and simulation in the medical device market. FEops’ simulation technology advances the field of predictive simulation for structural heart interventions and helps accelerate medical device innovation and regulatory decision-making.
In place of physically testing each size, computational modeling and simulation can predict implant size in a device family expected to perform the worst under simulated in vivo conditions, resulting in lower costs and less time spent at the bench.
Discover more details about the FDA’s stance on the benefits of computational modeling and simulation.
FEops simulation technology is used to perform accurate stress/strain analyses to determine fatigue safety factors